Yposkesi

@yposkesi

Yposkesi is one of the largest Contract Development & Manufacturing Organizations (CDMO) in Europe for manufacturing.🧪

Vrijeme pridruživanja: travanj 2018.

Tweetovi

Blokirali ste korisnika/cu @yposkesi

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @yposkesi

  1. 4. velj
    Poništi
  2. 31. sij

    FDA Finalizes 6 Gene Therapy Guidances, Unveils a New Draft

    Poništi
  3. 29. sij

    Yposkesi is proud to have produced batches of the lentiviral vector used in the X-Linked Chronic Granulomatous Disease study published in :

    Poništi
  4. 28. sij
    Poništi
  5. 24. sij

    Yposkesi shares its view with about some of the best practices for developing processes for : Mapping a Route for Cell and Gene Therapy Process Development

    Poništi
  6. 24. sij

    Researchers identify mechanism for how common vectors enter cells

    Poništi
  7. 23. sij

    @OutsourcPharm reports boom in number of UK clinical trials; most common therapeutic area is oncology.

    Poništi
  8. 20. sij
    Poništi
  9. 20. sij
    Poništi
  10. 15. sij

    Yposkesi présentera au grand public ses candidats-médicaments de thérapie génique pour les maladies rares à la Grande Exposition du Fabriqué en France à l’Elysée les 18 et 19 janvier 2020:

    Poništi
  11. 14. sij
    Poništi
  12. proslijedio/la je Tweet
    9. sij

    ., . Choose . as Mfg. Partner CDMO’s capacity to produce AAV materials at large-scale will support Genethon and Sarepta’s project to take micro-dystrophin to the clinic. Read more:

    Poništi
  13. 9. sij

    Yposkesi is proud to have been selected to produce clinical and large-scale commercial material of micro-dystrophin for the and program focused on muscular dystrophy:

    Poništi
  14. 27. pro 2019.
    Poništi
  15. 26. pro 2019.
    Poništi
  16. 24. pro 2019.
    Poništi
  17. proslijedio/la je Tweet
    19. pro 2019.

    Learn more about ARM’s & manufacturing initiatives here –

    Prikaži ovu nit
    Poništi
  18. 17. pro 2019.
    Poništi
  19. 9. pro 2019.

    After Approval, Can Achieve Marketing Success? - PharmaVOICE

    Poništi
  20. 9. pro 2019.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·